The differential diagnosis of AMKL mainly lies in histopathology, encompassing MDS 5q-, RARST (now MDS/MPN with SF3B1 mutation and thrombocytosis), panmyelofibrosis, and myeloproliferative tumors (including evolving cases). Here, SF3B1 is linked to Thrombocytosis.